Threats of tariffs and restrictive pricing policies involving major companies like Johnson & Johnson, Eli Lilly, and Roche, alongside Congressional planning.
4 reports, 2 independent
Updated Aug 5
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 4
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Threats of tariffs and restrictive pricing policies involving major companies like Johnson & Johnson, Eli Lilly, and Roche, alongside Congressional planning.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Potential tariff increases are being proposed in a bill by the House of Representatives.Sub-event
- Tax law provided certainty amid tariff uncertainty on August 5, 2025.Sub-event
- Trump pushed to normalize pricing in peer developed nations, while an analyst reviewed Eli Lilly's GLP-1 price hikes.Sub-event
Trump's policy threats regarding tariffs and pricing are being discussed in relation to J&J, Eli Lilly, Roche, and Congress.1 source
Keep exploring
The entities involved
-
Congress
US record label; imprint of Congress Record Corp.
-
Hoffmann-La Roche
Swiss healthcare company
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Related events
- The Institute for Supply Management noted on August 8, 2025, that tariffs from the Trump administration were causing market volatility and hurting industry and consumers.
- Trump's tariff plan caused markets to tank, impacting Donnelley Financial Solutions.
- The Trump administration is currently negotiating tariffs.
- A tariff plan caused market tanking, impacting companies Cintas and United Rentals.
- Trump's tariff plan caused markets to tank, affecting company Flo.
Coverage
Newest first; wire copies grouped- Pharma VoiceWhy drugmakers may need to borrow from quantum theory to confront tariff and pricing threats This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our f
- Motley FoolWhy Eli Lilly Stock Sank 18% This Week Eli Lilly is seeing strong growth from its weight loss drugs. Investors are nervous about tariffs on drugs and weak data from its upcoming pipeline. The stock i
- Motley FoolCan Eli Lilly Stock Withstand the Threat of President Trump's New Sweeping Tariffs? President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports. Lilly's margins could be ne